Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 892 Financials 884 Information Technology 517 Industrials 386 Consumer Discretionary 320 Communication Services 200 Consumer Staples 114 Materials 78 Energy 67 Real Estate 64 Utilities 27

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 471 Pharmaceuticals 159 Healthcare Equipment & Supplies 138 Healthcare Providers & Services 61 Life Sciences Tools & Services 38 Health Care Technology 25
Industry stocks

Pharmaceuticals Stocks on NASDAQ

Compare NASDAQ-listed Pharmaceuticals stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Pliant Therapeutics Inc (PLRX)
Fair Value48.9% Upside Undervalued Analyst143.9% Upside Market Cap50.516 M P/E— Yield0.0% HealthFair
  NASDAQ
PolyPid (PYPD)
Fair Value-26.4% Downside Overvalued Analyst101.1% Upside Market Cap115.2 M P/E— Yield0.0% HealthFair
  NASDAQ
PRF Technologies Ltd (PRFX)
Fair Value35.4% Upside Undervalued Market Cap2.655 M P/E— Yield0.0% HealthFair
  NASDAQ
Processa Pharmaceuticals Inc (PCSA)
Fair Value23.0% Upside Undervalued Market Cap6.167 M P/E— Yield0.0% HealthFair
  NASDAQ
Quantum BioPharma Ltd (QNTM)
Fair Value28.8% Upside Undervalued Analyst490.1% Upside Market Cap17.868 M P/E— Yield0.0% HealthWeak
  NASDAQ
Rani Therapeutics Holdings Inc (RANI)
Fair Value49.2% Upside Undervalued Market Cap71.956 M P/E— Yield0.0% HealthFair
  NASDAQ
Regencell Bioscience Holdings Ltd (RGC)
Fair Value29.3% Upside Undervalued Market Cap2.613 B P/E— Yield0.0% HealthWeak
  NASDAQ
Relmada Therapeutics Inc (RLMD)
Fair Value11.7% Upside Fair Analyst185.1% Upside Market Cap402.1 M P/E— Yield0.0% HealthGood
  NASDAQ Featured in High-Growth Small-Cap Stocks
Royalty Pharma Plc (RPRX)
Fair Value-7.4% Downside Fair Analyst-3.2% Downside Market Cap38.751 B P/E45.0x Yield1.4% HealthGreat
  NASDAQ
Scilex Holding Co (SCLX)
Fair Value68.1% Upside Bargain Market Cap11.959 M P/E— Yield163.9% HealthWeak
  NASDAQ
SNDL Inc (SNDL)
Fair Value50.9% Upside Bargain Analyst136.1% Upside Market Cap336.4 M P/E— Yield0.0% HealthGood
  NASDAQ
Tarsus Pharmaceuticals Inc (TARS)
Fair Value6.3% Upside Fair Analyst47.1% Upside Market Cap3.329 B P/E— Yield0.0% HealthGood
  NASDAQ
Tilray Inc (TLRY)
Fair Value28.9% Upside Undervalued Analyst103.6% Upside Market Cap412.1 M P/E— Yield0.0% HealthFair
  NASDAQ
Trevi Therapeutics Inc (TRVI)
Fair Value-28.3% Downside Overvalued Analyst120.0% Upside Market Cap1.825 B P/E— Yield0.0% HealthGood
  NASDAQ
Universe Pharmaceuticals Inc (UPC)
Fair Value36.8% Upside Undervalued Market Cap7.034 M P/E— Yield0.0% HealthWeak
  NASDAQ
Verrica Pharmaceuticals Inc (VRCA)
Fair Value58.4% Upside Bargain Analyst347.7% Upside Market Cap53.082 M P/E— Yield0.0% HealthFair
  NASDAQ
Vyome Holdings Inc (HIND)
Fair Value-1.6% Downside Fair Analyst441.9% Upside Market Cap11.44 M P/E— Yield0.0% HealthWeak
  NASDAQ
Xeris Pharmaceuticals Inc (XERS)
Fair Value-34.1% Downside Overvalued Analyst-1.7% Downside Market Cap2.385 B P/E— Yield0.0% HealthGreat
  NASDAQ Featured in High-Growth Small-Cap Stocks
60 Degrees Pharmaceuticals, Inc. (SXTP)
Analyst303.8% Upside Market Cap3.223 M P/E— Yield0.0% HealthWeak
  NASDAQ
Aardvark Therapeutics Inc (AARD)
Fair Value60.1% Upside Bargain Analyst575.7% Upside Market Cap24.292 M P/E— Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Momentum
Agomab Therapeutics Nv (AGMB)
Fair Value2.8% Upside Fair Analyst440.4% Upside Market Cap343.3 M P/E— Yield0.0% HealthGood
  NASDAQ
Akanda Corp (AKAN)
Fair Value25.1% Upside Undervalued Market Cap2.249 M P/E— Yield0.0% HealthWeak
  NASDAQ
Alumis Inc (ALMS)
Fair Value-1.1% Downside Fair Analyst432.1% Upside Market Cap757.2 M P/E— Yield0.0% HealthWeak
  NASDAQ
Amylyx Pharmaceuticals Inc (AMLX)
Fair Value-35.4% Downside Overvalued Analyst54.4% Upside Market Cap3.467 B P/E— Yield0.0% HealthFair
  NASDAQ
AN2 Therapeutics Inc (ANTX)
Fair Value-27.5% Downside Overvalued Analyst127.6% Upside Market Cap149.2 M P/E— Yield0.0% HealthGood
  NASDAQ
Aspire Biopharma Holdings Inc (ASBP)
Fair Value-2.5% Downside Fair Market Cap9.481 M P/E— Yield0.0% HealthFair
  NASDAQ
Belite Bio Inc ADR (BLTE)
Fair Value8.1% Upside Fair Analyst58.8% Upside Market Cap5.767 B P/E— Yield0.0% HealthFair
  NASDAQ
Bioage Labs Inc (BIOA)
Fair Value17.2% Upside Fair Analyst487.6% Upside Market Cap254.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Biofrontera Inc (BFRI)
Fair Value29.2% Upside Undervalued Analyst642.8% Upside Market Cap11.998 M P/E— Yield0.0% HealthFair
  NASDAQ
Biote Corp (BTMD)
Fair Value46.4% Upside Undervalued Analyst151.2% Upside Market Cap35.255 M P/E5.1x Yield0.0% HealthGood
  NASDAQ
Cadrenal Therapeutics Inc (CVKD)
Fair Value19.0% Upside Undervalued Market Cap3.568 M P/E— Yield0.0% HealthWeak
  NASDAQ
Cingulate Inc (CING)
Fair Value14.4% Upside Fair Analyst400.0% Upside Market Cap61.657 M P/E— Yield0.0% HealthFair
  NASDAQ
Clearmind Medicine Inc (CMND)
Fair Value35.8% Upside Undervalued Market Cap2.462 M P/E— Yield0.0% HealthWeak
  NASDAQ
Cognition Therapeutics Inc (CGTX)
Fair Value-3.2% Downside Fair Analyst424.9% Upside Market Cap60.423 M P/E— Yield0.0% HealthFair
  NASDAQ
Contineum Therapeutics Inc (CTNM)
Fair Value13.0% Upside Fair Analyst151.3% Upside Market Cap345.9 M P/E— Yield0.0% HealthWeak
  NASDAQ
Curanex Pharmaceuticals Inc (CURX)
Fair Value10.3% Upside Fair Market Cap9.064 M P/E— Yield0.0% HealthWeak
  NASDAQ
Gelteq Ltd (GELS)
Fair Value20.5% Upside Undervalued Market Cap5.095 M P/E— Yield0.0% HealthFair
  NASDAQ
Incannex Healthcare Ltd ADR (IXHL)
Fair Value45.8% Upside Undervalued Analyst719.5% Upside Market Cap28.476 M P/E— Yield0.0% HealthFair
  NASDAQ
Indivior PLC (INDV)
  NASDAQ
InterCure Ltd (INCR)
Fair Value43.6% Upside Undervalued Market Cap41.067 M P/E— Yield0.0% HealthFair
  NASDAQ
Journey Medical Corp (DERM)
Fair Value-3.6% Downside Fair Analyst219.8% Upside Market Cap121.4 M P/E— Yield0.0% HealthFair
  NASDAQ
Jupiter Neurosciences Inc (JUNS)
Fair Value15.8% Upside Fair Market Cap2.808 M P/E— Yield0.0% HealthWeak
  NASDAQ
LB Pharmaceuticals Inc (LBRX)
Fair Value6.4% Upside Fair Analyst52.3% Upside Market Cap1.229 B P/E— Yield0.0% HealthGood
  NASDAQ
Maze Therapeutics Inc (MAZE)
Fair Value-30.2% Downside Overvalued Analyst92.2% Upside Market Cap1.754 B P/E— Yield0.0% HealthGood
  NASDAQ
MBX Biosciences Inc (MBX)
Fair Value-22.4% Downside Overvalued Analyst97.5% Upside Market Cap2.334 B P/E— Yield0.0% HealthGood
  NASDAQ
Mira Pharmaceuticals Inc (MIRA)
Fair Value4.4% Upside Fair Analyst547.9% Upside Market Cap22.7 M P/E— Yield0.0% HealthWeak
  NASDAQ
Neonc Technologies Holdings Inc (NTHI)
Fair Value30.0% Upside Undervalued Analyst431.3% Upside Market Cap79.542 M P/E— Yield0.0% HealthWeak
  NASDAQ
NervGen Pharma Corp (NGEN)
Fair Value32.3% Upside Undervalued Analyst657.6% Upside Market Cap141.9 M P/E— Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Momentum
Neumora Therapeutics Inc (NMRA)
Fair Value-11.9% Downside Fair Market Cap91.505 M P/E— Yield0.0% HealthWeak
  NASDAQ
Polaryx Therapeutics Inc (PLYX)
Fair Value-18.3% Downside Overvalued Analyst331.0% Upside Market Cap86.732 M P/E— Yield0.0% HealthWeak
  NASDAQ
Explore listed stocks on NASDAQ with company information and fair value data.